BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
90 hedge funds and large institutions have $174M invested in BioSpecifics Technologies Corp. in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 37 increasing their positions, 30 reducing their positions, and 6 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 30
11% more capital invested
Capital invested by funds: $156M → $174M (+$17.4M)
0% more funds holding
Funds holding: 90 → 90 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
+$4.97M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$2.66M |
| 3 |
GC
Globeflex Capital
San Diego,
California
|
+$1.41M |
| 4 |
Renaissance Technologies
New York
|
+$1.22M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$839K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
-$3.44M |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$3.06M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$2.34M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$1.38M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.2M |
BSTC Hedge Fund Activity: Q3 2016 in Review
90 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q3 2016, worth a combined $174M — up 11% from $156M a quarter earlier.
Fund positioning in BSTC was balanced in Q3 2016: 6 funds opened new positions, 6 closed out, 37 added to existing stakes and 30 trimmed.
The largest buyer was Northpointe Capital, opening a new position worth an estimated $4.97M. The largest seller was RK Capital Management (Colorado), cutting an estimated $3.44M.
- 90 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $174M of BioSpecifics Technologies Corp. stock for Q3 2016, up 11% quarter-over-quarter.
- 6 funds opened new BioSpecifics Technologies Corp. positions in Q3 2016 and 6 closed out, a net change of 0 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q3 2016 was Northpointe Capital, an estimated $4.97M added.
- The largest BioSpecifics Technologies Corp. seller in Q3 2016 was RK Capital Management (Colorado), an estimated $3.44M sold.
Based on aggregated 13F filings for Q3 2016.